Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Faro AI Secures $37.3M in Series B Funding for Clinical Development

Guavy AI Editorial Team
Instruments
MRK
Share

Faro AI, a San Diego-based developer of structured data and AI infrastructure for modern clinical development, has secured $37.3 million in Series B funding.

The round was co-led by Merck Global Health Innovation Fund and S32, with participation from existing investors General Catalyst, Northpond Ventures, Polaris Partners, PTX Capital, Zetta, and new investor Ankona Capital.

Faro AI plans to use the funds to expand its agentic AI capabilities and accelerate work with customers deploying AI agents across their development organizations.

More on Stocks

Stocks 1m ago

JPMorgan Slashes CSC Development Target Price to HK$7 Amid Disappointing Results

Stocks 1m ago

JPMorgan Signals Openness to Stablecoin Launch Amid Market Shift

Stocks 1m ago

JPMorgan Boosts Pinewood Technologies Stake to 6.16%

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy